A Comparison of Healthcare Resource Utilization in EPIDIOLEX® (cannabidiol) Patients Before and After Treatment Initiation
Science & Innovation Webinar
Webinar Recorded on Oct. 5, 2021
Sponsored by Greenwich Biosciences, Inc.
Please Note: This webinar is intended for US formulary decision makers only.
Health economic outcomes research is becoming more important to formulary decision makers seeking to understand the true value of therapies utilizing real-world evidence.
In this webinar, experts will share and discuss the results of a retrospective claims analysis evaluating the impact of EPIDIOLEX on healthcare resource utilization (HCRU) and cost.
Join us to review the study outcomes and gain a deeper understanding of HCRU and costs pre- and post-EPIDIOLEX